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Since 1973, veterinary immunology has been a key aspect 
of research at ILRI and its predecessor, the International 
Laboratory for Research on Animal Diseases (ILRAD). 
ILRAD was specifically established to undertake basic 
research to develop effective and economic control 
measures for livestock diseases that seriously constrain 
global food production. As part of this mandate, ILRAD 
focused “initially on intensive research concerning 
the immunological and related aspects of controlling 
trypanosomiasis and theileriosis (mainly East Coast 
fever) …”, with the goal of decreasing the incidence and/
or severity of disease. Over the years, cutting edge tools, 
technologies and approaches have been implemented to 
increase understanding of the bovine immune system and 
mechanisms of pathogen control. Despite limited funding, 
compared to human immunological research, ILRAD/ILRI 
have made tremendous progress in bovine immunological 
research which remains a research focus at ILRI. 
Context:
Animal African Trypanosomiasis (AAT) and East Coast fever 
(ECF) are two diseases that severely constrain livestock 
production in sub-Saharan Africa. AAT is caused by 
trypanosome protozoans that live in blood and tissue fluids 
and are transmitted by tsetse flies. The disease prevents 
cattle ranching and mixed crop-livestock agriculture in 
vast areas across Africa (about 10 million km2), where 
tsetse and trypanosomiasis challenge is high. Cattle-based 
agriculture can be practiced on the fringe of the tsetse 
Did you know? 
•	 The investment made at ILRAD/ILRI to develop 
vaccines for AAT and ECF has been less than 1% of 
that invested in HIV and malaria research. However, 
ILRAD/ILRI’s research has made a significant 
contribution to immunological research worldwide. 
•	 Development of murine (rodent) monoclonal 
antibodies against bovine immune system 
biomarkers was a key milestone in ILRAD’s 
immunological research and in contributing to 
ruminant immunology worldwide. 
•	 Understanding how virus infected cells are killed 
proved transformative in the understanding of how 
immune responses control T. parva infected cells 
and thus ECF. 
•	 Ndama, a West African breed of cattle which 
is moderately tolerant of trypanosomaisis, 
were imported to ILRAD/ILRI as embryos 
from West Africa and implanted in cows in 
Kenya which served as surrogate mothers. The 
ILRAD/ILRI Ndama herd provided investigators 
with the opportunity to study mechanisms of 
trypanosomiasis resistance.
•	 ILRAD/ILRI has developed diagnostic tests for five 
major African tick-borne diseases of cattle.
•	 ILRI is adopting genomics based approaches 
to immunology, often described as “reverse” 
immunology, to tease apart both antibody and 
T-cell responses.
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response that is exploited by vaccination. Research 
at ILRAD/ILRI focused on African trypanosome and 
Theileria strain diversity, the nature of protective immune 
responses against these pathogens, and the identify of 
parasite components (putative vaccine antigens) that elicit 
protective immune responses.
Understanding Theileria parva
Infective Theileria particles (sporozoites) are spread by 
ticks. Once in the body, they invade host lymphocytes and 
cause them to multiply in an uncontrolled manner like a 
severe cancer of the immune system, which kills infected 
cattle in a few weeks. 
To support its research on mechanisms of infection and 
control, ILRAD recruited staff with expertise in what 
were then cutting edge immunology technologies. These 
techniques included the development of monoclonal 
antibodies, which are specific to a single antigen and 
produced by a single B cell and its progeny, and the 
generation of T cell clones that retain the specificity 
and function of their precursor T cell. The first 
ILRAD monoclonal antibodies were produced against 
trypanosome and theilerial antigens in the late 1970s, while 
the first T cell clones were produced in the mid 1980s. 
Furthermore, monoclonal antibodies were identified that 
prevented infection of cattle lymphocytes by Theileria 
sporozoites. These were found to react with a sporozoite 
coat protein called p67. The T. parva gene encoding this 
protein has been identified, cloned and expressed in 
bacteria providing material for ECF vaccine trials, which 
are ongoing. Similarly, Theileria genes that encode antigens 
that serve as targets for CD8 T cells, which play a role in 
immunity to ECF, have also been identified. 
It was first shown that CD8 T cells kill Theileria parva 
infected cells in vitro and upon transfer from immune cattle 
into infected naïve twins. These findings have thus focused 
research on antigens targeted by both antibodies and CD8 
T cells for inclusion in an ECF vaccine. 
Understanding tryps
African trypanosomes are transferred into mammals in the 
saliva of tsetse flies. The parasites invade, live and multiply 
in the blood plasma and tissue fluids of infected mammals. 
In trypanosomiasis susceptible hosts, including cattle and 
goats, the parasites cause chronic infections. 
Clearance of African trypanosomes from the infected host 
by the immune system is compromised due to variation 
of their glycoprotein coat (known as variable surface 
habitat, where trypanosome challenge is less, supported 
by chemotherapy and tsetse control. Yet despite these 
interventions, AAT results in a loss of US$ 4 billion/yr in 
productivity. 
ECF is caused by Theileria parva, another parasitic 
protozoan, which lives in the lymphocytes (white blood 
cells) and red blood cells of its mammalian host. ECF 
occurs in 11 countries in eastern, southern and central 
Africa and kills over 1 million cattle every year; annual 
economic losses as a result of ECF are valued at over 
US$300 million.
Understanding livestock immunity
When ILRAD’s research and support facilities were 
inaugurated in 1978, it was known from studies in mice 
and humans that lymphocytes (white blood cells that play 
a leading role in mammalian immune systems) could be 
divided into two groups: B cells and T cells. B cells primarily 
tackle extra-cellular disease-causing organisms (e.g. AAT) 
while T cells primarily tackle intra-cellular pathogens, 
(e,g. ECF). B cells create antibodies in the presence of a 
particular sub-component, or ‘antigen’, of the pathogen. 
T cells are divided into sub-groups which have specific 
roles. For example, cytotoxic (CD8) T lymphocytes 
destroy infected cells, whilst T helper lymphocytes (CD4) 
send ‘help’ signals to B cells and CD8 cytotoxic cells, and 
can themselves play a direct role in immunity to some 
pathogens. Often, all of these immune responses may work 
together to clear infections (e.g. ECF).
Immune systems in mammals have evolved to protect 
them against infection by pathogens and to initiate a 
rapid response if these agents are re-encountered; a 
Trypanosoma brucei
“The monoclonal antibodies produced at ILRAD and 
its early work with domestic animal infectious diseases 
set a standard of excellence for the world community 
working on infectious diseases of domestic animals, 
especially cattle.”
Gary Splitter, Professor of Veterinary Immunology, Uni-
versity of Wisconsin, USA
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glycoprotein - VSG). The vast number of antigenic variants 
of the trypanosome VSG, and the absence of conserved 
antigens on the trypanosome surface, prevented the ILRAD 
immunology team from developing a conventional vaccine 
that protects against infection with the parasites. 
The team turned their attention to trypanotolerance 
mechanisms in Cape buffalo, N’dama cattle and certain 
strains of inbred mice to determine ways to reduce the 
severity of trypanosomiasis-associated immunopathology 
in susceptible Boran cattle. Although the studies did not 
definitely identify resistance genes for Boran, they left 
a legacy of infection-induced immune response data. 
Furthermore, the investigatory team made some notable 
contributions to understanding trypanosome biology and 
immunology and contributed to immune response analysis 
of other antigenically variable parasites (see Shapiro quote)
In addition, immune response analyses in trypanosome 
infected AAT susceptible Boran cattle and AAT tolerant 
N’Dama cattle carried out at ILRAD/ILRI support the 
view that an appropriate T helper cell (CD4 T cell) 
response might facilitate host control of trypanosomiasis, 
a line of investigation that is currently being pursued by 
investigators outside of ILRI.
Providing global expertise
The tools, techniques and approaches developed by the 
ILRAD/ILRI immunological team are used worldwide and 
have facilitated in-depth immunological analyses of immune 
responses in cattle in general.
In addition, ILRAD/ILRI alumni hold senior scientific 
appointments at institutes throughout the world and 
continue their studies in veterinary immunology and 
parasitology. Whilst capacity building in this research 
area was not specifically a mandate of ILRAD/ILRI, there 
is no doubt that the expertise and facilities at ILRI 
have contributed to work on a wide range of diseases 
worldwide.
 
There is also no doubt that over the years, the ILRAD/
ILRI’s immunology and immunoparasitology research 
resulted in significant impact with much being achieved on 
a moderate budget. Output from the research programs 
includes monoclonal antibodies specific for bovine 
leukocytes and immunoglobulins, which are being used in 
many laboratories throughout the world. 
Whilst the immunology/immunoparasitology program 
has not affected the incidence of theileriosis or 
trypanosomiasis so far, it is envisaged that control for 
AAT and ECF will ultimately be achieved. It is particularly 
important to note that investment in the immunological 
control of these and other challenging diseases does 
not result in a quick fix, as is also evidenced by human 
immunological research into cancer, HIV/AIDS, and malaria 
(for which vaccines also do not exist). Nevertheless, 
immunological research at ILRI continues to focus on 
improving the ‘infection and treatment’ vaccine for ECF, as 
well as development of a recombinant subunit vaccine, and 
more recently on improving the vaccine for contagious 
bovine pleuropneumonia (CBPP) and peste des petits 
ruminants (PPR). 
Whilst in recent years, ILRI has curtailed its immunological 
based studies on AAT, it continues a focus on identifying 
traits and genes in mice and cattle that determine 
susceptibility and tolerance to the disease, which will, it 
is expected, expedite development of East African breeds 
of cattle that remain productive under trypanosomiasis 
pressure.
“The challenge of trying to make a vaccine against Afri-
can trypanosomes with their variable surface antigens 
prepared me to think about the challenges of making a 
vaccine against the extremely variable human 
immunodeficiency virus on which I now work.”
Stuart Shapiro, Vaccine Research Program, National 
Institute of Health, USA
Top tier scientists recruited to ILRAD were very will-
ing to establish collaborations with other scientists and 
share the reagents and protocols they produced. How-
ever, perhaps more important was that the critical mass 
of scientists at ILRAD in those early years generated 
very important questions regarding the mechanisms of 
how pathogens might cause disease. It was those ques-
tions that infused others beyond ILRAD with a scientific 
purpose.”
Gary Splitter, Professor of Veterinary Immunology, Univer-
sity of Wisconsin, USA
Natural Born Killer (cells)
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This is one of a series of briefs documenting the impacts 
of ILRI’s research.
It was prepared by WRENmedia with inputs by Samuel 
Black and Vish Nene.
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